Skip to main content

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Amedisys

(AMED) - Get Amedisys, Inc. Report

downgraded at UBS. Rating lowered to Neutral from Buy. Maintains $46 price target and 2009 EPS estimates of $4.57.

Affiliated Managers

(AMG) - Get Affiliated Managers Group, Inc. Report

upgraded at Credit Suisse from Neutral to Outperform. Estimates also boosted, to reflect an expected turnaround in asset inflows. Company may also be looking at accretive acquisitions. $69 price target.

Buffalo Wild Wings

(BWLD)

initiated at Jesup & Lamont with a Buy rating and $49 price target. Introduces 2009 estimates of $1.70.

Comcast

(CMCSA) - Get Comcast Corporation Class A Report

initiated at JP Morgan with an Overweight rating with a $19 price target. Introduces 2009 EPS estimates of $1.09.

TheStreet Recommends

Fiserv

(FISV) - Get Fiserv, Inc. Report

rated new Buy at Citigroup. $57 price target. Company is seeing internal growth recover and has positive operating leverage.

General Maritime

(GMR)

upgraded at FBR from Market Perform to Outperform. $9 price target. Dividend reduction should allow the company to buy vessels near trough valuations.

Deltek

(PROJ)

upgraded at Barclays to Overweight from Equal Weight on leverage to recovery. 2009 and 2010 EPS estimates cut from $0.54 to $0.52 and from $0.56 to $0.54, respectively. Price target raised to $10 from $7.

St. Jude Medical

(STJ)

upgraded at Wells Fargo to Outperform. ICD market should accelerate in 2010 and the stock is trading at a compelling valuation.

Time Warner Cable

(TWC)

initiated at JPMorgan. Initiated with an Overweight rating and $45 price target. Introduces 2009 EPS estimates of $2.99.

Wabtec

(WAB) - Get Westinghouse Air Brake Technologies Corporation Report

upgraded at Longbow from Neutral to Buy. $45 price target. New survey suggests that earnings should bottom out in 2009.

STOCK COMMENTS / EPS CHANGES

Corinthian Colleges

(COCO) - Get Vita Coco Company, Inc. Report

numbers increased at Merrill/BofA. Price target to $24 from $22 after COCO 's 4Q results beat expectations. 2010 and 2011 EPS estimates set at $1.34 and $1.71, respectively. Reiterate But rating.

Corinthian Colleges

(COCO) - Get Vita Coco Company, Inc. Report

price target raised at Barclays to $26 from $25 on belief that shares are too cheap. 2010 EPS estimate lifted to $1.35 from $1.19 and 2011 EPS estimate set at $1.61. Maintain Overweight rating.

Hain Celestial Group

(HAIN) - Get Hain Celestial Group, Inc. Report

estimates slashed at Goldman. 2010 and 2011 EPS estimates to $1.22 from $1.45 and to $1.35 from $1.65, respectively. Hain's business is stabilizing but 2010 earnings remain backend loaded said Goldman. Maintain Neutral rating and $20 price target.

Human Genome

(HGSI)

target raised at Weisel to $31. Potential for Benlysta is now more attractive, following a recent meeting with management. Overweight rating.

Medtronic

(MDT) - Get Medtronic Plc Report

target boosted at RBC to $38. Company posted a solid quarter. Sector Perform rating.

Medtronic

(MDT) - Get Medtronic Plc Report

estimates increased at Morgan Stanley. 2010 and 2011 EPS estimates to $3.18 from $3.14 and to $3.55 from $3.45, respectively. Analysts mentioned certain negative trends stabilizing or improving. Reiterate Equal Weight rating.

McCormick

(MKC) - Get McCormick & Company, Incorporated Report

estimates cut at Credit Suisse through 2010. Volume growth might not live up to expectations, though the quarter is still tracking relatively well. Neutral rating and $37 price target.

Myriad

(MYGN) - Get Myriad Genetics, Inc. Report

numbers mixed at Morgan Stanley. 2009 EPS estimate increased to $0.99 from $0.88 and 2010 EPS estimate lowered to $1.66 from $1.71. Maintain Equal Weight rating.

Regency Centers

(REG) - Get Regency Centers Corporation Report

estimates changed at Barclays. 2009 EPS estimate lowered to $2.40 from $2.42 and 2010 EPS estimated increased to $2.70 from $2.69. Maintain $36 price target and Overweight rating.

Staples

(SPLS)

estimates cut at Goldman. Reducing 2009 estimate by $0.02 to $1.10; 2010 by $0.02 to $1.33; and maintaining 2011 at $1.60. Maintain $25 price target and Buy rating.

Syniverse Holdings

(SVR)

price target boosted at Barclays to $21.50 from $20 after the acquisition of VRSN's mobile messaging biz. Maintain 2009 and 2010 EPS estimates of $1.52 and $1.64. Reiterate Overweight rating.

Veeco

(VECO) - Get Veeco Instruments Inc. Report

price target lifted at Merrill/BofA to $28 from $21 on continued LED strength. 2009 and 2010 EPS estimates set at -$0.39 and $0.95, respectively. Maintain Buy rating.

Werner

(WERN) - Get Werner Enterprises, Inc. Report

estimates increased at Morgan Stanley. 2009 and 2010 EPS estimates to $0.68 from $0.67 and to $0.89 from $0.86, respectively. Reiterate Underweight rating.

Winn-Dixie

(WINN)

estimates inflated at Barclays. 2009 and 2010 EPS estimates to $0.73 from $0.49 and to $0.23 from $0.21, respectively. Maintain Overweight rating and $16 price target.

--

Written by staff members in New York.

This article was written by a staff member of TheStreet.com.